Trial intelligence / Profile preview

Nebulised magnesium sulphate in acute severe asthma in children

2007-006227-12Phase 3Completed

Sponsor
Cardiff University
Start
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in status asthmaticus and asthma comparing Nebulised magnesium sulphate + standard therapy with Placebo + standard therapy (2 arms). Primary endpoint: Yung Asthma Severity Score at 60 minutes. Started Feb 2008; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

status asthmaticusasthma

Beyond the preview

Go deeper on 2007-006227-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006227-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call